Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1992 1
1995 1
1997 1
1998 1
2000 1
2001 1
2003 3
2004 2
2005 4
2006 2
2008 2
2009 5
2010 7
2011 6
2012 7
2013 7
2014 11
2015 12
2016 14
2017 14
2018 7
2019 3
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 28912284

95 results
Results by year
Filters applied: . Clear all
Page 1
T1-Weighted Dynamic Contrast-Enhanced MR Perfusion Imaging Characterizes Tumor Response to Radiation Therapy in Chordoma.
Santos P, Peck KK, Arevalo-Perez J, Karimi S, Lis E, Yamada Y, Holodny AI, Lyo J. Santos P, et al. AJNR Am J Neuroradiol. 2017 Nov;38(11):2210-2216. doi: 10.3174/ajnr.A5383. Epub 2017 Sep 14. AJNR Am J Neuroradiol. 2017. PMID: 28912284 Free PMC article.
Differentiating Atypical Hemangiomas and Metastatic Vertebral Lesions: The Role of T1-Weighted Dynamic Contrast-Enhanced MRI.
Morales KA, Arevalo-Perez J, Peck KK, Holodny AI, Lis E, Karimi S. Morales KA, et al. AJNR Am J Neuroradiol. 2018 May;39(5):968-973. doi: 10.3174/ajnr.A5630. Epub 2018 Apr 12. AJNR Am J Neuroradiol. 2018. PMID: 29650780 Free PMC article.
Morphological and dynamic contrast enhanced MR imaging features for the differentiation of chordoma and giant cell tumors in the Axial Skeleton.
Lang N, Su MY, Xing X, Yu HJ, Yuan H. Lang N, et al. J Magn Reson Imaging. 2017 Apr;45(4):1068-1075. doi: 10.1002/jmri.25414. Epub 2016 Aug 4. J Magn Reson Imaging. 2017. PMID: 27490009 Free PMC article.
Prediction of pseudoprogression in patients with glioblastomas using the initial and final area under the curves ratio derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging.
Suh CH, Kim HS, Choi YJ, Kim N, Kim SJ. Suh CH, et al. AJNR Am J Neuroradiol. 2013 Dec;34(12):2278-86. doi: 10.3174/ajnr.A3634. Epub 2013 Jul 4. AJNR Am J Neuroradiol. 2013. PMID: 23828115 Free article.
T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status.
Arevalo-Perez J, Thomas AA, Kaley T, Lyo J, Peck KK, Holodny AI, Mellinghoff IK, Shi W, Zhang Z, Young RJ. Arevalo-Perez J, et al. AJNR Am J Neuroradiol. 2015 Dec;36(12):2256-61. doi: 10.3174/ajnr.A4484. Epub 2015 Sep 3. AJNR Am J Neuroradiol. 2015. PMID: 26338913 Free PMC article.
Evaluation of microvascular permeability with dynamic contrast-enhanced MRI for the differentiation of primary CNS lymphoma and glioblastoma: radiologic-pathologic correlation.
Kickingereder P, Sahm F, Wiestler B, Roethke M, Heiland S, Schlemmer HP, Wick W, von Deimling A, Bendszus M, Radbruch A. Kickingereder P, et al. AJNR Am J Neuroradiol. 2014 Aug;35(8):1503-8. doi: 10.3174/ajnr.A3915. Epub 2014 Apr 10. AJNR Am J Neuroradiol. 2014. PMID: 24722313 Free article.
Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma.
Lin X, Lee M, Buck O, Woo KM, Zhang Z, Hatzoglou V, Omuro A, Arevalo-Perez J, Thomas AA, Huse J, Peck K, Holodny AI, Young RJ. Lin X, et al. AJNR Am J Neuroradiol. 2017 Mar;38(3):485-491. doi: 10.3174/ajnr.A5023. Epub 2016 Dec 8. AJNR Am J Neuroradiol. 2017. PMID: 27932505 Free PMC article.
MRI evaluation of sacral chordoma treated with carbon ion radiotherapy alone.
Preda L, Stoppa D, Fiore MR, Fontana G, Camisa S, Sacchi R, Ghitti M, Viselner G, Fossati P, Valvo F, Vitolo V, Bonora M, Iannalfi A, Vischioni B, Vai A, Mastella E, Baroni G, Orecchia R. Preda L, et al. Radiother Oncol. 2018 Aug;128(2):203-208. doi: 10.1016/j.radonc.2017.11.029. Epub 2017 Dec 23. Radiother Oncol. 2018. PMID: 29279241
Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
Akisik MF, Sandrasegaran K, Bu G, Lin C, Hutchins GD, Chiorean EG. Akisik MF, et al. Radiology. 2010 Aug;256(2):441-9. doi: 10.1148/radiol.10091733. Epub 2010 Jun 1. Radiology. 2010. PMID: 20515976 Clinical Trial.
Glioma: Application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading.
Jung SC, Yeom JA, Kim JH, Ryoo I, Kim SC, Shin H, Lee AL, Yun TJ, Park CK, Sohn CH, Park SH, Choi SH. Jung SC, et al. AJNR Am J Neuroradiol. 2014 Jun;35(6):1103-10. doi: 10.3174/ajnr.A3825. Epub 2014 Jan 2. AJNR Am J Neuroradiol. 2014. PMID: 24384119 Free article.
95 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback